News >

The Pressure for Drug Pricing Reform Intensifies

Tony Hagen @oncobiz
Published: Monday, Jun 19, 2017

Jayson S. Slotnik

Jayson S. Slotnik

Regulatory actions have significantly reduced oncologists’ pay in recent years, as part of the effort to improve value, but reforms are needed much higher up the drug distribution chain, a panel of pharmaceutical industry professionals said at the Oncology Market Access & Pricing conference held in Philadelphia this month by eyeforpharma.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x